Tenax Therapeutics | SCHEDULE 13G/A:其他
Tenax Therapeutics | 3:首次持股声明-股东 Dellora Investments LP
Tenax Therapeutics | 4:持股变动声明-高管 Rich Stuart
Tenax Therapeutics | 4:持股变动声明-董事 PROEHL GERALD T
Tenax Therapeutics | 4:持股变动声明-董事 Hunter Robyn
Tenax Therapeutics | 4:持股变动声明-高管 Giordano Christopher Thomas
Tenax Therapeutics | 4:持股变动声明-董事 Doogan Declan
Tenax Therapeutics | 4:持股变动声明-董事 Davidson Michael H.
Tenax Therapeutics | 4:持股变动声明-董事 Almenoff June Sherie
Tenax Therapeutics | 3:首次持股声明-高管 MCGAULEY THOMAS
Tenax Therapeutics | SCHEDULE 13G:其他
Tenax Therapeutics | 8-K:重大事件
Tenax Therapeutics | S-8:员工福利计划证券登记
Tenax Therapeutics | SC 13G:超过5%持股股东披露文件-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%)等
Tenax Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(10.0%),Janus Henderson Biotech Innovation Master Fund Ltd(10.0%)
Tenax Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-CVI Investments, Inc.(0%),Heights Capital Management, Inc.(0%)
Tenax Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Stonepine Capital Management, LLC(9.99%),Stonepine Capital, L.P(9.99%)等
Tenax Therapeutics | 10-Q:2024财年三季报
Tenax Therapeutics | 8-K:Tenax Therapeutics公布2024年第三季度财务业绩并提供公司最新情况
Tenax Therapeutics | SC 13G:超过5%持股股东披露文件-Adage Capital Management, L.P.(9.99%),Robert Atchinson(9.99%)等